Using data from the Ultimate I and II phase 3 trials, researchers conducted a post-hoc analysis to study the effects of ublituximab on disease activity in relapsing multiple sclerosis.
In light of Pain Awareness and Arthritis Awareness Month, Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.
Study leads Shilpa Venkatachalam, MD, and Michael George, MD, discuss the highlights of a new initiative to track the effects of COVID-19 in autoimmune disorders.
The European League Against Rheumatism developed recommendations for the collection, analysis, and use of big data in rheumatic and musculoskeletal disorders.
Researchers measured discordance between patient or family and physician global activity scores in juvenile dermatomyositis, and determined factors associated with discordance.
